Product Description This looseleaf provides precedent agreements and legal commentary in relation to the main types of commercial transaction encountered in the life-cycle of a product in the biotechnology and pharmaceutical industries. Each agreement is accompanied by detailed commentary on legal, commercial and practice issues. In addition the commentary will highlight important differences between English law and other key EU jurisdictions comprising Germany, France, the Netherlands, Spain and Sweden with specific commentary being provided by specialist lawyers within these countries. Further commentary on the US specific issues will be provided in the first updating release. The third part of the looseleaf incorporates a separate summary and discussion of legal issues that are common to different types of agreement, relevant statutory and legal materials and website links to other relevant materials. The looseleaf is published with an accompanying online resource providing plain versions of all the precedents which can be downloaded and edited to enable the user to create and amend precedents based on those provided by the work. Annual updating releases will provide both new precedent material and commentary covering important developments within the field. About the Author Mark Anderson is a solicitor and former barrister, who founded Anderson & Company in 1994. He has a degree in law from Durham University. Caroline de Mareuil-Villette is a European Patent Attorney at Cabinet Plasseraud, France Magali Touroude is a European Patent Attorney at Cabinet Plasseraud, France Dr. Christine Kanz is a Partner and Attorney at Reimann Osterrieth Köhler Haft, Germany Dr. Heike Wachenhausen is a Lawyer at Anwaltskanzlei Sträter, Germany Carla Schoonderbeek is a Partner and Head of the Life Sciences team at Nauta Dutilh, Netherlands Eric Runesson is a Partner at Sandart & Partners, Sweden Pablo Olivera is a Partner at Garrigues, Spain Dulce Mª Miranda Naranjo is a European Patent Attorney, Garrigues, Spain